Science Explorer Back to mapMap
Discussion
Researcher · Centre Oscar Lambret · France

Farid El Hajbi

Farid El Hajbi publishes mostly in Surgery, Oncology and Pulmonary and Respiratory Medicine, on topics such as Esophageal Cancer Research and Treatment, Cancer Immunotherapy and Biomarkers and Colorectal and Anal Carcinomas.

OpenAlex
World rank
#661,304
of 7,710,434 ranked researchers
Rank in France
#33,027
of 324,115
Works
88
Citations
3.6k
Citations per work
40.6
h-index
22
i10-index 32Top 13% in Surgery
Farid El Hajbi

What does Farid El Hajbi research?

Farid El Hajbi's work is mostly in Medicine (81%), Biochemistry, Genetics and Molecular Biology (3%).

Health Sciences: 71 works · 80.7% of their workMedicine: 71 works · 80.7% of their workSurgery: 29 works · 32.5% of their workOncology: 26 works · 29.1% of their workPulmonary and Respiratory Medicine: 10 works · 10.8% of their workEpidemiology: 4 works · 4.9% of their workPathology and Forensic Medicine: 3 works · 3.4% of their workEverything else: 14 works · 16.3% of their workLife Sciences: 3 works · 3.0% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 3.0% of their workCancer Research: 3 works · 3.0% of their workTHEIR WORKFarid El Hajbi88works
Life Sciences3%Health Sciences81%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine7180.7%
  2. Everything else1416.3%
    1. Biochemistry, Genetics and Molecular Biology33.0%
  1. 1Surgery32% of their works
  2. 2Oncology29% of their works
  3. 3Pulmonary and Respiratory Medicine11% of their works
  4. 4Epidemiology5% of their works
  5. 5Pathology and Forensic Medicine3% of their works
  6. 6Cancer Research3% of their works

Research topics

Which keywords describe Farid El Hajbi's research?

The keywords of their largest research topics: Chemotherapy, Chemoradiation, Neoadjuvant Therapy, Endoscopic Resection, Epidemiology, Tumor Microenvironment, Esophageal Carcinoma and Preoperative Chemoradiotherapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 23 words, with their numbers
  1. Chemotherapy514 topics
  2. Chemoradiation402 topics
  3. Neoadjuvant Therapy372 topics
  4. Endoscopic Resection362 topics
  5. Epidemiology322 topics
  6. Tumor Microenvironment322 topics
  7. Esophageal Carcinoma241 topic
  8. Preoperative Chemoradiotherapy241 topic
  9. Immune Checkpoint Blockade191 topic
  10. PD-1 and PD-L1191 topic
  11. Survival Analysis182 topics
  12. Anal Cancer161 topic
  13. Intensity-Modulated Radiation Therapy161 topic
  14. Pancreatic Cancer131 topic
  15. Surgical Complications131 topic
  16. Gastric Cancer121 topic
  17. Molecular Characterization121 topic
  18. Cetuximab101 topic
  19. KRAS Mutations101 topic
  20. Biliary Tract Cancer81 topic
  21. Cholangiocarcinoma81 topic
  22. Neuroendocrine Tumors61 topic
  23. Pancreatic Neuroendocrine Tumors61 topic

Where does Farid El Hajbi work?

Farid El Hajbi's main affiliation in the publication record is Centre Oscar Lambret, France.

How many publications and citations does Farid El Hajbi have?

OpenAlex counts 88 works and 3,571 citations for Farid El Hajbi, an h-index of 22, ranking #661,304 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Farid El Hajbi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.